General Electric to Sell Biopharma Business to Danaher for US$21.4 B

By Michelle Liu

Pharma Deals Review: Vol 2019 Issue 3 (Table of Contents)

Published: 13 Mar-2019

DOI: 10.3833/pdr.v2019.i3.2412     ISSN: 1756-7874

Section: Mergers & Acquisitions



In its largest deal to date, Danaher has agreed to buy General Electric’s (GE) biopharmaceutical business, GE Biopharma, for US$21...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details